03 August 2018
Visiongain has launched a new pharma report Clinical Trial Supply and Logistics Market for Pharma 2018-2028: Clinical Trial Manufacturing, Clinical Trial Logistics and Distributions, Clinical Trial Supply Chain Management, Clinical Trial Packaging, Clinical Trial Cold Chain Logistics
Pharmaceutical service providers offer a wide variety of services to drug developers and other clinical trial sponsors that form a vital part of the clinical trial supply chain. For the purposes of this report, visiongain identified three main sectors of the clinical trial supply and logistics market:
• Clinical trial material manufacturing and packaging services
• Clinical trial logistics and distribution services
• Other supply chain management services
Across the pharmaceutical industry, outsourcing has become an increasingly popular way to cut costs across all aspects of the business, by reducing internal capacity - in terms of sites maintained and headcount.
The lead analyst of the report commented “Clinical trial globalisation will continue to drive growth of this market, stimulating demand for international distribution services. Globalisation will generate complex trial supply chains, requiring greater planning and logistics support.
Technological advancements will also drive the growth in clinical trial supply and logistics market, providing efficient planning and real-time data analysis to improve supply chains mid-trial. Drug pooling for multi-trial programmes will drive the demand for regional depot network with strong transport networks to trial sites.”
Leading companies featured in the report include World Courier, DHL, Marken, FedEx, Movianto, Catalent, Patheon, Almac Group, Parexel International, Fisher Clinical Services, Packaging Coordinators Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Visiongain anticipates that the global precision medicine market is projected to witness a CAGR of 12% over the forecast period from 2020 to 2030. The global precision medicine market is anticipated to surpass US$ 67 billion in 2020 and is further projected to surpass US$ 200 billion in 2030.
27 May 2020
The global colon targeting drug delivery market is projected to grow at a CAGR of 8.07% in the first half of the forecast period. Visiongain anticipate that the global market will witness a CAGR of 9.23% during the forecast period 2020 to 2030.
27 May 2020
The automation in biopharma industry market is estimated to grow at a CAGR of 4.3% over the forecast period.
22 May 2020
The global erectile dysfunction is in a transition phase as the majority of the consumers are shifting from traditional pharmaceuticals to herbal-based products pertaining to lesser side effects and positive perception of natural products amongst the society. Visiongain understands this market to be dynamic, with a large number of players to enter the market.”